HER2-Low and Ultralow Metastatic Breast Cancer: Evolving Definitions, Emerging Evidence, and Shifting Treatment Paradigms

Join us for a timely and informative West Coast-timed webinar on HER2-Low and Ultralow Metastatic Breast Cancer: Evolving Definitions, Emerging Evidence, and Shifting Treatment Paradigms, featuring internationally recognized breast medical oncologist Dr. Aditya Bardia, who will share the latest insights and clinical trial data shaping global practice. Offering the Canadian perspective is Dr. Mita Manna, a respected breast cancer expert based in Western Canada, who will moderate the session and explore how these evolving advances are being integrated into clinical care across the region. Don't miss this opportunity to gain valuable guidance on navigating the changing landscape of HER2-low and ultralow disease.